NEW YORK, May 29 – AlphaGene said Tuesday it had appointed Robert Brown, a neurology professor at Harvard Medical School, as a member of its scientific advisory board.

Brown will work with AlphaGene of Woburn, Mass., to find novel genes associated with a recessive form of Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease.

Brown, who is also director of the Day Neuromuscular Research Laboratory at Massachusetts General Hospital, helped to define mutations in the gene encoding SOD1 as one cause of hereditary ALS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.